These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 19508398)

  • 1. To scale or not to scale: the principles of dose extrapolation.
    Sharma V; McNeill JH
    Br J Pharmacol; 2009 Jul; 157(6):907-21. PubMed ID: 19508398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research tools for extrapolating the disposition and pharmacokinetics of nanomaterials from preclinical animals to humans.
    Valic MS; Zheng G
    Theranostics; 2019; 9(11):3365-3387. PubMed ID: 31244958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic Organic Anion Transporting Polypeptide-Mediated Clearance in the Beagle Dog: Assessing In Vitro-In Vivo Relationships and Applying Cross-Species Empirical Scaling Factors to Improve Prediction of Human Clearance.
    Matsunaga N; Ufuk A; Morse BL; Bedwell DW; Bao J; Mohutsky MA; Hillgren KM; Hall SD; Houston JB; Galetin A
    Drug Metab Dispos; 2019 Mar; 47(3):215-226. PubMed ID: 30593544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interspecies scaling and comparisons in drug development and toxicokinetics.
    Ings RM
    Xenobiotica; 1990 Nov; 20(11):1201-31. PubMed ID: 2275215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part II: Mechanistic Models and In Vitro-In Vivo Extrapolation.
    Scotcher D; Jones C; Posada M; Galetin A; Rostami-Hodjegan A
    AAPS J; 2016 Sep; 18(5):1082-1094. PubMed ID: 27506526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development.
    Mahmood I
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1177-92. PubMed ID: 17826864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetic principles behind scaling from preclinical results to phase I protocols.
    Mahmood I; Balian JD
    Clin Pharmacokinet; 1999 Jan; 36(1):1-11. PubMed ID: 9989339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of human drug clearance from two species: a comparison of several allometric methods.
    Goteti K; Garner CE; Mahmood I
    J Pharm Sci; 2010 Mar; 99(3):1601-13. PubMed ID: 19827101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of clearance and volume of distribution in the obese from normal weight subjects: an allometric approach.
    Mahmood I
    Clin Pharmacokinet; 2012 Aug; 51(8):527-42. PubMed ID: 22671778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scaling pharmacodynamics from in vitro and preclinical animal studies to humans.
    Mager DE; Woo S; Jusko WJ
    Drug Metab Pharmacokinet; 2009; 24(1):16-24. PubMed ID: 19252333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling concentrations of antimicrobial drugs: comparative pharmacokinetics of cephalosporin antimicrobials and accuracy of allometric scaling in food-producing and companion animals.
    Taverne FJ; van Geijlswijk IM; Heederik DJ; Wagenaar JA; Mouton JW
    BMC Vet Res; 2016 Sep; 12(1):185. PubMed ID: 27596044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges.
    Masimirembwa CM; Bredberg U; Andersson TB
    Clin Pharmacokinet; 2003; 42(6):515-28. PubMed ID: 12793837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretation of Non-Clinical Data for Prediction of Human Pharmacokinetic Parameters: In Vitro-In Vivo Extrapolation and Allometric Scaling.
    Choi GW; Lee YB; Cho HY
    Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30959827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically based pharmacokinetics (PBPK).
    Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
    Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misconceptions and issues regarding allometric scaling during the drug development process.
    Mahmood I
    Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):843-854. PubMed ID: 29999428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
    Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
    Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of metabolic drug clearance in humans: in vitro-in vivo extrapolation vs allometric scaling.
    Shiran MR; Proctor NJ; Howgate EM; Rowland-Yeo K; Tucker GT; Rostami-Hodjegan A
    Xenobiotica; 2006 Jul; 36(7):567-80. PubMed ID: 16864504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interspecies extrapolation.
    Kenyon EM
    Methods Mol Biol; 2012; 929():501-20. PubMed ID: 23007441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.
    Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of allometric scaling as a tool for extrapolation of the enrofloxacin dose in American black vultures
    Waxman S; Prados AP; De Lucas JJ; Wiemeyer G; Torres-Bianchini L; Andres MIS; Rodríguez C
    Am J Vet Res; 2019 Aug; 80(8):727-735. PubMed ID: 31339763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.